Xiaoqing Lu Boynton is a Senior Director at ASG, where she advises clients on government affairs strategies to support their success in the China market. She helps clients navigate Chinese industry policy issues, particularly in the healthcare and life sciences sector.
Ms. Boynton most recently served as a Fellow with the Global Health Policy Center at the Center for Strategic and International Studies (CSIS). Previously, she was a Fellow with the CSIS Freeman Chair in China Studies, where she worked on projects related to China’s domestic socioeconomic transformation. She also consulted for Eurasia Group and Global Health Strategies (GHS) on health issues in China. She also worked at the Woodrow Wilson Center and the American Bar Association’s Asia Law Initiative in Beijing.
Ms. Boynton is a coauthor of several CSIS reports on health and environmental issues in China, including “Implementing Health Care Reform Policies in China: Challenges and Opportunities” (December 2011), “China’s Health amidst the Global Economic Crisis: Potential Effects and Challenges” (October 2009), “Assessing Chinese Government Response to the Challenge of Environment and Health” (July 2008), and “China’s Civil Society Organizations: What Future in the Health Sector” (November 2007). She was also the editor of “China’s Capacity to Manage Infectious Diseases” (April 2009). She has authored articles on nontraditional security threats in China’s environment and health sectors in the South China Morning Post, the China Environment Series, published by the Woodrow Wilson International Center for Scholars, and Global AIDSLink, published by the Global Health Council.
Ms. Boynton holds a M.A. in International Development from Brandeis University and a B.A. in International Economics and Trade from Beijing Second Foreign Language University.
She is fluent in Mandarin Chinese.
Ms. Boynton is based in Washington, DC.